BioSpace News Archive

Reaching a new milestone in the industrial implementation of the C-StemTM technology, TreeFrog Therapeutics announces the opening of a 13,000 sq ft facility aimed at scaling-up cell therapy manufacturing processes based on induced pluripotent stem (iPS) cells.

Turnover reaches €3,793 million, with an increase of 3.2% compared to 2018 and EBITDA of €492 million thanks to continued strong performance of its most important products

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with a proprietary line of functional “supplement” chewing gums (versions: infused with CBD, CBG, Vitamin C & Zinc) and edibles product(s) as well as two ongoing Biotechnology initiatives, today

PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Thermo Fisher Scientific for the development and manufacturing of PMC-309, a next-generation immune checkpoint blockade to treat cancer.

Shreya Ramesh was named the overall winner of the International BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research and innovation in biotechnology.

bioAffinity Technologies, a privately held biotech company, today announced its test validation trial for CyPath® Lung resulted in specificity of 88% and sensitivity of 82%, similar to far more invasive procedures commonly used to diagnose lung cancer.

Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—hosted a Virtual NCCN Policy Summit titled Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020.

Medical Marketing & Media (MM&M) is transitioning its U.S. events to virtual settings for the remainder of 2020. The shift includes its annual awards ceremony, conferences and other live activations.

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced the partnership with Berry Genomics, headquartered in the People’s Republic of China.

Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company, today announced its financial and operating results for the three-month period and year ended March 31, 2020